Cecilia Linde

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: EUROPEAN HEART JOURNAL. 2024;:ehae596

Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.

Schnabel RB; Benezet-Mazuecos J; Becher N; McIntyre WF; Fierenz A; Lee SF; Goette A; Atar D; Bertaglia E; Benz AP; Chlouverakis G; Birnie DH; Dichtl W; Blomstrom-Lundqvist C; Camm AJ; Erath JW; Simantirakis E; Kutyifa V; Lip GYH; Mabo P; Marijon E; Rivard L; Schotten U; Alings M; Sehner S; Toennis T; Linde C; Vardas P; Granger CB; Zapf A; Lopes RD; Healey JS; Kirchhof P
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2024;13(15):e031785

Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis

Shivakumar N; Friedman DJ; Fudim M; Abraham WT; Cleland JGF; Curtis AB; Gold MR; Kutyifa V; Linde C; Young J; Tang A; Olivas-Martinez A; Inoue LYT; Sanders GD; Al-Khatib SM
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2024

Characterizing atrial fibrillation in patients with and without heart failure across the ejection fraction spectrum: Incidence, prevalence, and treatment strategies

Valente V; Ferrannini G; Benson L; Gatti P; Guidetti F; Melin M; Braunschweig F; Linde C; Dahlstrom U; Lund LH; Fudim M; Savarese G
Article: ESC HEART FAILURE. 2024

Rates and predictors of cardiovascular and non-cardiovascular outcomes in heart failure with preserved ejection fraction

Shahim A; Donal E; Hage C; Oger E; Savarese G; Persson H; Haugen-Loefman I; Ennezat P-V; Sportouch-Dukhan C; Drouet E; Daubert J-C; Linde C; Lund LH
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2024;84(4):354-364

Apixaban vs Aspirin According to CHA ₂ DS ₂-VASc Score in Subclinical Atrial Fibrillation From ARTESiA

Lopes RD; Granger CB; Wojdyla DM; Mcintyre WF; Alings M; Mani T; Ramasundarahettige C; Rivard L; Atar D; Birnie DH; Boriani G; Amit G; Leong-Sit P; Rinne C; Duray GZ; Gold MR; Hohnloser SH; Kutyifa V; Benezet-Mazuecos J; Nielsen JC; Sticherling C; Benz AP; Linde C; Kautzner J; Mabo P; Mairesse GH; Connolly SJ; Healey JS
Article: HEART RHYTHM. 2024;21(6):845-854

Relationship between sex, body size, and cardiac resynchronization therapy bene fit: A patient-level meta-analysis of randomized controlled trials

Friedman DJ; Olivas-Martinez A; Dalgaard F; Fudim M; Abraham WT; Cleland JGF; Curtis AB; Gold MR; Kutyifa V; Linde C; Tang AS; Ali-Ahmed F; Inoue LYT; Sanders GD; Al-Khatib SM
Article: ESC HEART FAILURE. 2024

Iron deficiency in new onset heart failure: association with clinical factors and quality of life

Cabrera CC; Ekstrom M; Tornvall P; Lofstrom U; Frisk C; Linde C; Hage C; Persson H; Eriksson MJ; Wallen H; Persson B; Lynga P
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2024;26(4):1039-1046

Comorbidities and clinical response to cardiac resynchronization therapy: patient-level meta-analysis from eight clinical trials

Fudim M; Dalgaard F; Friedman DJ; Abraham WT; Cleland JGF; Curtis AB; Gold MR; Kutyifa V; Linde C; Ali-Ahmed F; Tang A; Olivas-Martinez A; Inoue LYT; Al-Khatib SM; Sanders GD
Article: SCIENTIFIC REPORTS. 2024;14(1):5811

Cardiac biopsies reveal differences in transcriptomics between left and right ventricle in patients with or without diagnostic signs of heart failure

Frisk C; Das S; Eriksson MJ; Walentinsson A; Corbascio M; Hage C; Kumar C; Ekstroem M; Maret E; Persson H; Linde C; Persson B
Article: PRESSE MEDICALE. 2024;53(1):104192

Electrical therapies in heart failure: Evolving technologies and indications

Linde C
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2024;26(2):483-501

Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)

Mullens W; Dauw J; Gustafsson F; Mebazaa A; Steffel J; Witte KK; Delgado V; Linde C; Vernooy K; Anker SD; Chioncel O; Milicic D; Hasenfuss G; Ponikowski P; Stephan von Bardeleben R; Koehler F; Ruschitzka F; Damman K; Schwammenthal E; Testani JM; Zannad F; Boehm M; Cowie MR; Dickstein K; Jaarsma T; Filippatos G; Volterrani M; Thum T; Adamopoulos S; Cohen-Solal A; Moura B; Rakisheva A; Ristic A; Bayes-Genis A; Van Linthout S; Tocchetti CG; Savarese G; Skouri H; Adamo M; Amir O; Yilmaz MB; Simpson M; Tokmakova M; Gonzalez A; Piepoli M; Seferovic P; Metra M; Coats AJS; Rosano GMC
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2024;390(2):107-117

Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

Healey JS; Lopes RD; Granger CB; Alings M; Rivard L; McIntyre WF; Atar D; Birnie DH; Boriani G; Camm AJ; Conen D; Erath JW; Gold MR; Hohnloser SH; Ip J; Kautzner J; Kutyifa V; Linde C; Mabo P; Mairesse G; Benezet Mazuecos J; Cosedis Nielsen J; Philippon F; Proietti M; Sticherling C; Wong JA; Wright DJ; Zarraga IG; Coutts SB; Kaplan A; Pombo M; Ayala-Paredes F; Xu L; Simek K; Nevills S; Mian R; Connolly SJ
Article: AMERICAN HEART JOURNAL. 2024;267:81-90

Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysis

Zeitler EP; Dalgaard F; Abraham WT; Cleland JGF; Curtis AB; Friedman DJ; Gold MR; Kutyifa V; Linde C; Tang AS; Olivas-Martinez A; Inoue LYT; Sanders GD; Al-Khatib SM
Article: EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES. 2023;9(8):741-748

What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey II

Gatti P; Linde C; Benson L; Thorvaldsen T; Normand C; Savarese G; Dahlstrom U; Maggioni AP; Dickstein K; Lund LH
Article: JOURNAL OF CLINICAL MEDICINE. 2023;12(22):7182

Cardiac Magnetic Resonance Identifies Responders to Cardiac Resynchronization Therapy with an Assessment of Septal Scar and Left Ventricular Dyssynchrony

Larsen CK; Smiseth OA; Duchenne J; Galli E; Aalen JM; Lederlin M; Bogaert J; Kongsgaard E; Linde C; Penicka M; Donal E; Voigt J-U; Hopp E
Article: JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY. 2023;34(9):1914-1924

Cardiac resynchronization therapy in patients with a prior history of atrial fibrillation: Insights from four major clinical trials

Dalgaard F; Fudim M; Al-Khatib SM; Friedman DJ; Abraham WT; Cleland JGF; Curtis AB; Gold MR; Kutyifa V; Linde C; Young J; Ali-Ahmed F; Tang A; Olivas-Martinez A; Inoue LYT; Sanders GD
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2023;25(8):1270-1280

Iron deficiency in heart failure: screening, prevalence, incidence and outcome data from the Swedish Heart Failure Registry and the Stockholm CREAtinine Measurements collaborative project

Lindberg F; Lund LH; Benson L; Linde C; Orsini N; Carrero JJ; Savarese G
Article: EUROPACE. 2023;25(7):euad192

Prognosis of CRT-treated and CRT-untreated unselected population with LBBB in Stockholm County

Gatti P; Lind S; Kristjansdottir I; Azari A; Savarese G; Anselmino M; Linde C; Gadler F
Article: CLINICAL KIDNEY JOURNAL. 2023;16(7):1160-1169

Rationale and design of CONTINUITY: a Phase 4 randomized controlled trial of continued post-discharge sodium zirconium cyclosilicate treatment versus standard of care for hyperkalemia in chronic kidney disease

Burton JO; Allum AM; Amin A; Linde C; Lesen E; Mellstrom C; Eudicone JM; Sood MM
Article: ESC HEART FAILURE. 2023;10(3):1835-1846

Long-term outcomes in heart failure with preserved ejection fraction: Predictors of cardiac and non-cardiac mortality

Shahim A; Hourqueig M; Lund LH; Savarese G; Oger E; Venkateshvaran A; Benson L; Daubert J-C; Linde C; Donal E; Hage C
Article: HEART RHYTHM. 2023;20(6):863-871

Outcomes of conduction system pacing for cardiac resynchronization therapy in patients with heart failure: A multicenter experience

Ezzeddine FM; Pistiolis SM; Pujol-Lopez M; Lavelle M; Wan EY; Patton KK; Robinson M; Lador A; Tamirisa K; Karim S; Linde C; Parkash R; Birgersdotter-Green U; Russo AM; Chung M; Cha Y-M
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2023;379:82-88

Relationship between iron deficiency and expression of genes involved in iron metabolism in human myocardium and skeletal muscle

Cabrera C; Frisk C; Lofstrom U; Lynga P; Linde C; Hage C; Persson H; Eriksson MJ; Wallen H; Persson B; Ekstrom M
Article: CIRCULATION. 2023;147(10):812-823

Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials

Friedman DJ; Al-Khatib SM; Dalgaard F; Fudim M; Abraham WT; Cleland JGF; Curtis AB; Gold MR; Kutyifa V; Linde C; Tang AS; Ali-Ahmed F; Olivas-Martinez A; Inoue LYT; Sanders GD
Article: HEART RHYTHM. 2023;20(2):173-180

Association of left ventricular remodeling with cardiac resynchronization therapy outcomes

Gold MR; Rickard J; Daubert JC; Cerkvenik J; Linde C
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2022;24(12):2275-2284

Cardiac contractility modulation therapy improves health status in patients with heart failure with preserved ejection fraction: a pilot study (CCM-HFpEF)

Linde C; Grabowski M; Ponikowski P; Rao I; Stagg A; Tschoepe C
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2022;24(11):2093-2104

Trajectories in New York Heart Association functional class in heart failure across the ejection fraction spectrum: data from the Swedish Heart Failure Registry

Lindberg F; Lund LH; Benson L; Dahlstrom U; Karlstrom P; Linde C; Rosano G; Savarese G
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING. 2022;23(10):1373-1382

Left atrial strain is a predictor of left ventricular systolic and diastolic reverse remodelling in CRT candidates

Galli E; Oger E; Aalen JM; Duchenne J; Larsen CK; Sade E; Hubert A; Gallard A; Penicka M; Linde C; Le Rolle V; Hernandez A; Leclercq C; Voigt J-U; Smiseth OA; Donal E
Article: ESC HEART FAILURE. 2022;9(4):2125-2138

Baseline characteristics of 547 new onset heart failure patients in the PREFERS heart failure study

Linde C; Ekstrom M; Eriksson MJ; Maret E; Wallen H; Lynga P; Weden U; Cabrera C; Lofstrom U; Stenudd J; Lund LH; Persson B; Persson H; Hage C
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2022;24(7):1212-1222

Predictors of primary prevention implantable cardioverter-defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all-cause mortality

Schrage B; Lund LH; Benson L; Dahlstrom U; Shadman R; Linde C; Braunschweig F; Levy WC; Savarese G
Article: HEART RHYTHM. 2022;19(4):595-603

The importance of early evaluation after cardiac resynchronization therapy to redefine response: Pooled individual patient analysis from 5 prospective studies

Chung ES; Gold MR; Abraham WT; Young JB; Linde C; Anderson C; Lu X; Ikuemonisan JO; Fagan DH; Tsintzos SI; Rickard J
Article: ESC HEART FAILURE. 2022;9(2):822-833

Patient profile and outcomes associated with follow-up in specialty vs. primary care in heart failure

Lindberg F; Lund LH; Benson L; Schrage B; Edner M; Dahlstrom U; Linde C; Rosano G; Savarese G
Article: TURK KARDIYOLOJI DERNEGI ARSIVI. 2022;50(3):182-191

Upgrades from Previous Cardiac Implantable Electronic Devices Compared to De Novo Cardiac Resynchronization Therapy Implantations: Results from CRT Survey-II in the Turkish Population

Kocyigit D; Sarigul NU; Altin T; Cay S; Normand C; Linde C; Dickstein K
Article: ESC HEART FAILURE. 2022;9(1):164-177

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trial

Lund LH; Savarese G; Venkateshvaran A; Benson L; Lundberg A; Donal E; Daubert J-C; Oger E; Linde C; Hage C
Article: EUROPACE. 2022;24(1):48-57

Cardiac resynchronization therapy with or without defibrillator in patients with heart failure.

Schrage B; Lund LH; Melin M; Benson L; Uijl A; Dahlström U; Braunschweig F; Linde C; Savarese G
Article: EUROPACE. 2022;24(1):165-172

European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology

Aktaa S; Abdin A; Arbelo E; Burri H; Vernooy K; Blomstrom-Lundqvist C; Boriani G; Defaye P; Deharo J-C; Drossart I; Foldager D; Gold MR; Johansen JB; Leyva F; Linde C; Michowitz Y; Kronborg MB; Slotwiner D; Steen T; Tolosana JM; Tzeis S; Varma N; Glikson M; Nielsen JC; Gale CP
Article: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2022;9:952974

Extracellular vesicles in heart failure - A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting

Matan D; Mobarrez F; Lofstrom U; Corbascio M; Ekstrom M; Hage C; Lynga P; Persson B; Eriksson M; Linde C; Persson H; Wallen H
Article: ESC HEART FAILURE. 2021;8(5):4243-4254

Predictors of long-term outcome in heart failure with preserved ejection fraction: a follow-up from the KaRen study

Shahim A; Hourqueig M; Donal E; Oger E; Venkateshvaran A; Daubert J-C; Savarese G; Linde C; Lund LH; Hage C
Article: EUROPACE. 2021;23(8):1324-1342

Optimized Implementation of cardiac resynchronization therapy - a call for action for referral and optimization of care A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology

Mullens W; Auricchio A; Martens P; Witte K; Cowie MR; Delgado V; Dickstein K; Linde C; Vernooy K; Leyva F; Bauersachs J; Israel CW; Lund LH; Donal E; Boriani G; Jaarsma T; Berruezo A; Traykov V; Yousef Z; Kalarus Z; Nielsen JC; Steffel J; Vardas P; Coats A; Seferovic P; Edvardsen T; Heidbuchel H; Ruschitzka F; Leclercq C
Article: JACC-CLINICAL ELECTROPHYSIOLOGY. 2021;7(7):871-880

Redefining the Classifications of Response to Cardiac Resynchronization Therapy Results From the REVERSE Study

Gold MR; Rickard J; Daubert JC; Zimmerman P; Linde C
Article: ESC HEART FAILURE. 2021;8(3):1827-1839

Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score

Huttin O; Fraser AG; Lund LH; Donal E; Linde C; Kobayashi M; Erdei T; Machu J-L; Duarte K; Rossignol P; Paulus W; Zannad F; Girerd N
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2021;331:144-151

Prognostic utility of the assessment of diastolic function in patients undergoing cardiac resynchronization therapy

Galli E; Smiseth OA; Aalen JM; Larsen CK; Sade E; Hubert A; Anilkumar S; Penicka M; Linde C; Le Rolle V; Hernandez A; Leclercq C; Duchenne J; Voigt J-U; Donal E
Article: JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY. 2021;34(5):494-502

Importance of Systematic Right Ventricular Assessment in Cardiac Resynchronization Therapy Candidates: A Machine Learning Approach

Galli E; Le Rolle V; Smiseth OA; Duchenne J; Aalen JM; Larsen CK; Sade EA; Hubert A; Anilkumar S; Penicka M; Linde C; Leclercq C; Hernandez A; Voigt J-U; Donal E
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. HYPERTENSION. 2021;8:100074

Ambulatory blood pressure monitoring and blood pressure control in patients with coronary artery disease-A randomized controlled trial

Hagglund O; Svensson P; Linde C; Ostergren J
Article: JOURNAL OF INTERNAL MEDICINE. 2021;289(3):369-384

Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real-world data from the Swedish Heart Failure Registry

Savarese G; Hage C; Benson L; Schrage B; Thorvaldsen T; Lundberg A; Fudim M; Linde C; Dahlstrom U; Rosano GMC; Lund LH
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2021;55(1):1-8

Reorganization of heart failure management and improved outcome - the 4D HF Project

Matan D; Lofstrom U; Cabrera CC; Eriksson B; Ekstrom M; Hage C; Ljunggren G; Lynga P; Wallen H; Malmqvist KK; Linde C; Persson H
Article: ANATOLIAN JOURNAL OF CARDIOLOGY. 2020;24(6):382-396

Current clinical practice of cardiac resynchronization therapy in Turkey: Reflections from Cardiac Resynchronization Therapy Survey-II

Kocyigit D; Sarigul NU; Altin AT; Cay S; Polat V; Saygi S; Gumrukcuoglu HA; Gemici K; Ikitimur B; Akyol A; Bilge AK; Basarici I; Ozcan EE; Demir M; Kabul HK; Ornek E; Normand C; Linde C; Dickstein K
Article: JOURNAL OF CARDIAC FAILURE. 2020;26(12):1050-1059

Metabolomic Profile in HFpEF vs HFrEF Patients

Hage C; Lofgren L; Michopoulos F; Nilsson R; Davidsson P; Kumar C; Ekstrom M; Eriksson MJ; Lynga P; Persson B; Wallen H; Gan LM; Persson H; Linde C
Article: EUROPEAN HEART JOURNAL. 2020;41(39):3813-3823

Imaging predictors of response to cardiac resynchronization therapy: left ventricular work asymmetry by echocardiography and septal viability by cardiac magnetic resonance

Aalen JM; Donal E; Larsen CK; Duchenne J; Lederlin M; Cvijic M; Hubert A; Voros G; Leclercq C; Bogaert J; Hopp E; Fjeld JG; Penicka M; Linde C; Aalen OO; Kongsgard E; Galli E; Voigt J-U; Smiseth OA
Article: JOURNAL OF CARDIOVASCULAR MEDICINE. 2020;21(9):634-640

Second European Society of Cardiology Cardiac Resynchronization Therapy Survey: the Italian cohort

Botto GL; Gasparini M; Brasca FMA; Casale MC; Occhetta E; Racheli M; Bertaglia M; Zanon F; Zardini M; Rapacciuolo A; Mascioli G; Curnis A; Metra M; Normand C; Dickstein K; Linde C
Article: ESC HEART FAILURE. 2020;7(4):1534-1546

Myeloperoxidase and related biomarkers are suggestive footprints of endothelial microvascular inflammation in HFpEF patients

Hage C; Michaelsson E; Kull B; Miliotis T; Svedlund S; Linde C; Donal E; Daubert J-C; Gan L-M; Lund LH
Article: IRISH JOURNAL OF MEDICAL SCIENCE. 2020;189(3):895-905

CRT Survey II: a European Society of Cardiology (ESC) survey of cardiac resynchronization therapy-an Irish subset analysis

Ranganathan D; Sharif Z; Murphy T; Mahon N; Normond C; Linde C; Dickstein K; Sheahan R
Article: JOURNAL OF CARDIAC FAILURE. 2020;26(8):673-684

Do Patients With Acute Heart Failure and Preserved Ejection Fraction Have Heart Failure at Follow-Up: Implications of the Framingham Criteria

Hage C; Lofstrom U; Donal E; Oger E; Kaplon-Cieslicka A; Daubert J-C; Linde C; Lund LH
Article: CLINICAL RESEARCH IN CARDIOLOGY. 2020;109(7):832-844

Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II

Lawin D; Israel CW; Linde C; Normand C; Dickstein K; Lober C; Gitt AK; Hindricks G; Stellbrink C
Article: ARCHIVES OF CARDIOVASCULAR DISEASES. 2020;113(6-7):381-390

Heart failure with preserved ejection fraction: A clustering approach to a heterogenous syndrome

Schrub F; Oger E; Bidaut A; Hage C; Charton M; Daubert JC; Leclercq C; Linde C; Lund L; Donal E
Article: EUROPACE. 2020;22(6):932-938

Adherence to ESC cardiac resynchronization therapy guidelines: findings from the ESC CRT Survey II

Normand C; Linde C; Blomstrom-Lundqvist C; Stellbrink C; Gasparini M; Anker SD; Plummer C; Sarigul NU; Papiashvili G; Iovev S; Dickstein K
Article: SCIENTIFIC REPORTS. 2020;10(1):8029

Myocardial micro-biopsy procedure for molecular characterization with increased precision and reduced trauma

Grankvist R; Chireh A; Sandell M; Mukarram AK; Jaff N; Berggren I; Persson H; Linde C; Arnberg F; Lundberg J; Ugander M; La Manno G; Jonsson S; Daub CO; Holmin S
Article: AMERICAN HEART JOURNAL. 2020;223:48-58

Future research prioritization in cardiac resynchronization therapy

Fudim M; Dalgaard F; Al-Khatib SM; Friedman DJ; Lallinger K; Abraham WT; Cleland JGF; Curtis AB; Gold MR; Kutyifa V; Linde C; Schaber DE; Tang A; Ali-Ahmed F; Goldstein SA; Kaufman B; Fortman R; Davis JK; Inoue LYT; Sanders GD
Article: EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES. 2020;6(2):147-155

Outcome and presentation of heart failure in breast cancer patients: findings from a Swedish register-based study

Hedayati E; Papakonstantinou A; Gernaat SAM; Altena R; Brand JS; Alfredsson J; Bhoo-Pathy N; Herrmann J; Linde C; Dahlstrom U; Bergh J; Hubbert L
Article: ESC HEART FAILURE. 2020;7(2):737-746

The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS Hypertension study

Ekstrom M; Hellman A; Hasselstrom J; Hage C; Kahan T; Ugander M; Wallen H; Persson H; Linde C
Article: ESC HEART FAILURE. 2020;7(2):445-455

Circulating neuregulin1-β in heart failure with preserved and reduced left ventricular ejection fraction

Hage C; Wardell E; Linde C; Donal E; Lam CSP; Daubert C; Lund LH; Mansson-Broberg A
Article: EUROPEAN HEART JOURNAL. 2020;41(2):255-323

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

Cosentino F; Grant PJ; Aboyans V; Bailey CJ; Ceriello A; Delgado V; Federici M; Filippatos G; Grobbee DE; Hansen TB; Huikuri HV; Johansson I; Jüni P; Lettino M; Marx N; Mellbin LG; Östgren CJ; Rocca B; Roffi M; Sattar N; Seferović PM; Sousa-Uva M; Valensi P; Wheeler DC; ESC Scientific Document Group
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2019;72(12):1020-1030

Spanish Results of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II)

Cano O; Bellver A; Fontenla A; Villuendas R; Penafiel P; Francisco-Pascual J; Luis Ibanez J; Bertomeu-Gonzalez V; Garcia-Riesco L; Garcia-Seara J; Martinez-Brotons A; Calvo D; Campos B; Enero J; Pelaez A; Martinez-Ferrer J; Mazuelos F; Luis Morinigo J; Exposito C; Arenal A; Pombo M; Segura F; Pastor A; Perez F; Fernandez-Lozano I; Jose Gonzalez-Ferrer J; Moreno S; Martin-Fernandez J; Ormaetxe J; Pavon R; Maria Tolosana J; Merce J; Garcia-Almagro F-J; Alvarez M; Macias A; Peinado R; Linde C; Normand C; Dickstein K
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2019;8(22):e012655

Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom

Linde C; Bakhai A; Furuland H; Evans M; McEwan P; Ayoubkhani D; Qin L
Article: CIRCULATION. 2019;140(19):1530-1539

Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure Registry

Schrage B; Uijl A; Benson L; Westermann D; Stahlberg M; Stolfo D; Dahlstrom U; Linde C; Braunschweig F; Savarese G
Article: ARCHIVES OF CARDIOVASCULAR DISEASES. 2019;112(11):713-722

The European Society of Cardiology Cardiac Resynchronization Therapy Survey II: A L updates comparison of cardiac resynchronization therapy implantation practice in Europe and France

Galand V; Linde C; Lellouche N; Mansourati J; Deharo J-C; Sagnol P; Da Costa A; Horvilleur J; Defaye P; Boveda S; Steinbach M; Bru P; Rumeau P; Beard T; Younsi S; Dickstein K; Normand C; Leclercq C
Article: JACC-CLINICAL ELECTROPHYSIOLOGY. 2019;5(9):1048-1058

Sex-Related Procedural Aspects and Complications in CRT Survey II A Multicenter European Experience in 11,088 Patients

Auricchio A; Gasparini M; Linde C; Dobreanu D; Cano O; Sterlinski M; Bogale N; Stellbrink C; Refaat MM; Blomstrom-Lundqvist C; Lober C; Dickstein K; Normand C
Article: ESC HEART FAILURE. 2019;6(4):830-839

Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fraction

Lofstrom U; Hage C; Savarese G; Donal E; Daubert J-C; Lund LH; Linde C
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2019;287:66-72

N-terminal pro-B-type natriuretic peptide in chronic heart failure: The impact of sex across the ejection fraction spectrum

Faxen UL; Lund LH; Orsini N; Stromberg A; Andersson DC; Linde C; Dahlstrom U; Savarese G
Article: EUROPACE. 2019;21(6):918-927

Cardiac resynchronization therapy pacemaker or cardiac resynchronization therapy defibrillator: what determines the choice?-findings from the ESC CRT Survey II

Normand C; Linde C; Bogale N; Blomstrom-Lundqvist C; Auricchio A; Stellbrink C; Witte KK; Mullens W; Sticherling C; Marinskis G; Sciaraffia E; Papiashvili G; Iovev S; Dickstein K
Article: ESC HEART FAILURE. 2019;6(2):280-290

Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK

Linde C; Qin L; Bakhai A; Furuland H; Evans M; Ayoubkhani D; Palaka E; Bennett H; McEwan P
Article: SCIENTIFIC REPORTS. 2019;9(1):3179

Transcriptomics of cardiac biopsies reveals differences in patients with or without diagnostic parameters for heart failure with preserved ejection fraction

Das S; Frisk C; Eriksson MJ; Walentinsson A; Corbascio M; Hage C; Kumar C; Asp M; Lundeberg J; Maret E; Persson H; Linde C; Persson B
Article: BMC NEPHROLOGY. 2019;20(1):31

The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease

Evans M; Palaka E; Furuland H; Bennett H; Linde C; Qin L; McEwan P; Bakhai A
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2019;53(1):21-27

ST2 in heart failure with preserved and reduced ejection fraction

Najjar E; Faxen UL; Hage C; Donal E; Daubert J-C; Linde C; Lund LH
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2019;53(1):9-13

Contemporary practice of CRT implantation in scandinavia compared to Europe

Steen T; Sciaraffia E; Normand C; Bogale N; Dickstein K; Linde C; Philbert BT
Article: GEORGIAN MEDICAL NEWS.. 2019;(286):50-54

EUROPEAN CARDIAC RESYNCHRONIZATION THERAPY SURVEY II: COMPARISON OF RESULTS IN GEORGIA WITH OTHER COUNTRIES.

Papiashvili G; Machitidze G; Linde C; Normand C; Dickstein K
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2019;274:202-207

Importance of structural heart disease and diastolic dysfunction in heart failure with preserved ejection fraction assessed according to the ESC guidelines - A substudy in the Ka (Karolinska) Ren (Rennes) study

Persson H; Donal E; Lund LH; Matan D; Oger E; Hage C; Daubert J-C; Linde C
Article: POSTEPY W KARDIOLOGII INTERWENCYJNEJ. 2019;15(4):477-484

Cardiac resynchronization in Poland - comparable procedural routines? Insights from CRT Survey II

Tajstra M; Lasocha D; Gadula-Gacek E; Ostrega M; Michalak L; Wojciechowski D; Zielinski M; Kempa M; Orski Z; Polewczyk A; Ozga J; Normand C; Dickstein K; Linde C; Kazmierczak J; Szumowski L; Gasior M; Sterlinski M
Article: KARDIOLOGIA POLSKA. 2019;77(1):40-46

Do we differ in terms of indications and demographics in cardiac resynchronisation recipients in Poland? Insights from the European CRT Survey II Registry

Lasocha D; Sterlinski M; Tajstra M; Josiak K; Zajac D; Tluczek S; Sokal A; Januszkiewicz LJ; Galar B; Sznaider R; Kazmierczak J; Szumowski L; Normand C; Linde C; Dickstein K
Article: JOURNAL OF MEDICAL ECONOMICS. 2018;21(12):1172-1182

Development of a health economic model to evaluate the potential benefits of optimal serum potassium management in patients with heart failure

Bakhai A; Palaka E; Linde C; Bennett H; Furuland H; Qin L; McEwan P; Evans M
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2018;52(6):348-355

Cost effectiveness of implementing ESC guidelines for treatment of iron deficiency in heart failure in the Nordic countries

Hofmarcher T; Alin DC; Linde C
Article: CARDIOLOGY RESEARCH AND PRACTICE. 2018;2018:3479846-8

Croatian National Data and Comparison with European Practice: Data from the Cardiac Resynchronization Therapy Survey II Multicenter Registry

Brusich S; Zeljkovic I; Pavlovic N; Anic A; Jurisic Z; Zidan D; Klasan M; Cubranic Z; Dickstein K; Linde C; Normand C; Manola S
Article: EUROPACE. 2018;20(10):1565-1565ao

Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society

Linde C; Bongiorni MG; Birgersdotter-Green T; Curtis AB; Deisenhofer I; Furokawa T; Gillis AM; Haugaa KH; Lip GYH; Van Gelder I; Malik M; Poole J; Potpara T; Savelieva I; Sarkozy A; Fauchier L; Kutyifa V; Ernst S; Gandjbakhch E; Marijon E; Casadei B; Chen Y-J; Swampillai J; Hurwitz J; Varma N
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2018;267:128-132

Patient reported outcome in HFpEF: Sex-specific differences in quality of life and association with outcome

Faxen UL; Hage C; Donal E; Daubert J-C; Linde C; Lund LH
Article: BMC NEPHROLOGY. 2018;19(1):211

Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink

Furuland H; McEwan P; Evans M; Linde C; Ayoubkhani D; Bakhai A; Palaka E; Bennett H; Qin L
Article: SWISS MEDICAL WEEKLY. 2018;148:w14643

Cardiac Resynchronisation Therapy (CRT) Survey II: CRT implantation in Europe and in Switzerland.

Zeljkovic I; Burri H; Breitenstein A; Ammann P; Mueller A; Auricchio A; Delacrétaz E; Dickstein K; Linde C; Normand C; Sticherling C
Article: COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES. 2018;71(6):859-864

EUROPEAN CRT SURVEY II - BULGARIAN DATA

Iovev S; Staneva M; Dickstein K; Normand C; Linde C
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2018;121(12):1558-1566

Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction

Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert J-C; Linde C; Lund LH
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2018;20(6):1039-1051

CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how?

Dickstein K; Normand C; Auricchio A; Bogale N; Cleland JG; Gitt AK; Stellbrink C; Anker SD; Filippatos G; Gasparini M; Hindricks G; Lundqvist CB; Ponikowski P; Ruschitzka F; Botto GL; Bulava A; Duray G; Israel C; Leclercq C; Margitfalvi P; Cano O; Plummer C; Sarigul NU; Sterlinski M; Linde C
Article: JACC-HEART FAILURE. 2018;6(4):308-316

Indications for Cardiac Resynchronization Therapy A Comparison of the Major International Guidelines

Normand C; Linde C; Singh J; Dickstein K
Article: JOURNAL OF INTERNAL MEDICINE. 2018;283(4):380-391

Left atrial rather than left ventricular impaired mechanics are associated with the pro-fibrotic ST2 marker and outcomes in heart failure with preserved ejection fraction

Nagy AI; Hage C; Merkely B; Donal E; Daubert J-C; Linde C; Lund LH; Manouras A
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2018;20(4):780-791

The interaction of sex, height, and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality: an individual-patient data meta-analysis

Linde C; Cleland JGF; Gold MR; Daubert JC; Tang ASL; Young JB; Sherfesee L; Abraham WT
Article: EUROPEAN HEART JOURNAL. 2018;39(6):434-441

The year in cardiology 2017: arrhythmias and cardiac devices

Linde C; Steffel J
Article: KARDIOLOGIA POLSKA. 2018;76(1):107-118

Haematological indices as predictors of atrial fibrillation following isolated coronary artery bypass grafting, valvular surgery, or combined procedures: a systematic review with meta-analysis

Weymann A; Ali-Hasan-Al-Saegh S; Popov A-F; Sabashnikov A; Mirhosseini SJ; Liu T; Tse G; Lotfaliani M; Ghanei A; Testa L; D'Ascenzo F; Benedetto U; Dehghan H; Roever L; Barros de Oliveira Sa MP; Baker WL; Yavuz S; Zeriouh M; Mashhour A; Nombela-Franco L; Jang J-S; Meng L; Gong M; Deshmukh AJ; Palmerini T; Linde C; Filipiak KJ; Biondi-Zoccai G; Calkins H; Stone GW
Article: KARDIOLOGIA POLSKA. 2018;76(2):440-451

Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery: a systematic review and meta-analysis

Weymann A; Popov A-F; Sabashnikov A; Ali-Hasan-Al-Saegh S; Ryazanov M; Tse G; Mirhosseini SJ; Liu T; Lotfaliani M; Sedaghat M; Baker WL; Ghanei A; Yavuz S; Zeriouh M; Izadpanah P; Dehghan H; Testa L; Nikfard M; Barros de Oliveira Sa MP; Mashhour A; Nombela-Franco L; Rezaeisadrabadi M; D'Ascenzo F; Zhigalov K; Benedetto U; Najafi SA; Szczechowicz M; Roever L; Meng L; Gong M; Deshmukh AJ; Palmerini T; Linde C; Filipiak KJ; Stone GW; Biondi-Zoccai G; Calkins H
Article: SCIENTIFIC REPORTS. 2017;7(1):12941

Spatial detection of fetal marker genes expressed at low level in adult human heart tissue

Asp M; Salmen F; Stahl PL; Vickovic S; Felldin U; Lofling M; Navarro JF; Maaskola J; Eriksson MJ; Persson B; Corbascio M; Persson H; Linde C; Lundeberg J
Article: CIRCULATION-HEART FAILURE. 2017;10(10):e004111

Precision Medicine for Cardiac Resynchronization Predicting Quality of Life Benefits for Individual Patients-An Analysis From 5 Clinical Trials

Nassif ME; Tang Y; Cleland JG; Abraham WT; Linde C; Gold MR; Young JB; Daubert JC; Sherfesee L; Schaber D; Tang ASL; Jones PG; Arnold SV; Spertus JA
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2017;19(10):1270-1279

Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry

Lund LH; Braunschweig F; Benson L; Stahlberg M; Dahlstrom U; Linde C
Article: EUROPACE. 2017;19(9):1556-1578

Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart RhythmSociety (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)

Gorenek B; Bax J; Boriani G; Chen S-A; Dagres N; Glotzer TV; Healey JS; Israel CW; Kudaiberdieva G; Levin L-A; Lip GYH; Martin D; Okumura K; Svendsen JH; Tse H-F; Botto GL; Sticherling C; Linde C; Kutyifa V; Bernat R; Scherr D; Lau C-P; Iturralde P; Morin DP; Savelieva I
Article: JACC-CLINICAL ELECTROPHYSIOLOGY. 2017;3(8):818-826

The Impact of the PR Interval in Patients Receiving Cardiac Resynchronization Therapy: Results From the REVERSE Study.

Senfield J; Daubert C; Abraham WT; Ghio S; St John Sutton M; Cerkvenik J; Linde C; Gold MR
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2017;19(8):1056-1063

Predictors of short-term clinical response to cardiac resynchronization therapy

Linde C; Abraham WT; Gold MR; Daubert JC; Tang ASL; Young JB; Sherfesee L; Hudnall JH; Fagan DH; Cleland JG
Article: HEART AND VESSELS. 2017;32(6):735-749

The prognostic significance of atrial fibrillation in heart failure with preserved ejection function: insights from KaRen, a prospective and multicenter study

Bosseau C; Donal E; Lund LH; Oger E; Hage C; Mulak G; Daubert J-C; Linde C
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING. 2017;18(6):629-635

Importance of combined left atrial size and estimated pulmonary pressure for clinical outcome in patients presenting with heart failure with preserved ejection fraction

Donal E; Lund LH; Oger E; Bosseau C; Reynaud A; Hage C; Drouet E; Daubert J-C; Linde C
Article: PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. 2017;40(5):504-513

Effects of Spinal Cord Stimulation on Cardiac Sympathetic Nerve Activity in Patients with Heart Failure

Naar J; Jaye D; Linde C; Neuzil P; Doskar P; Malek F; Braunschweig F; Lund LH; Mortensen L; Linderoth B; Lind G; Bone D; Scholte AJ; Kueffer F; Koehler J; Shahgaldi K; Lang O; Stahlberg M
Article: JOURNAL OF CARDIAC FAILURE. 2017;23(4):293-303

HFpEF and HFrEF Display Different Phenotypes as Assessed by IGF-1 and IGFBP-1

Faxen UL; Hage C; Benson L; Zabarovskaja S; Andreasson A; Donal E; Daubert J-C; Linde C; Brismar K; Lund LH
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2017;19(3):366-376

New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy

Braunschweig F; Linde C; Benson L; Stahlberg M; Dahlstrom U; Lund LH
Article: JACC-HEART FAILURE. 2017;5(3):169-178

Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization Results From the REVERSE Trial

Sutton MSJ; Linde C; Gold MR; Abraham WT; Ghio S; Cerkvenik J; Daubert J-C
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2017;228:709-716

HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin

Faxen UL; Hage C; Andreasson A; Donal E; Daubert J-C; Linde C; Brismar K; Lund LH
Article: CIRCULATION-GENOMIC AND PRECISION MEDICINE. 2017;10(1):e001633

Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction A Holistic Proteomic Approach

Hage C; Michaelsson E; Linde C; Donal E; Daubert J-C; Gan L-M; Lund LH
Article: HEART FAILURE CLINICS. 2017;13(1):241-251

Cardiac Resynchronization Therapy Follow-up Role of Remote Monitoring

Linde C; Braunschweig F
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2017;226:65-70

Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study

Savarese G; Donal E; Hage C; Oger E; Persson H; Daubert J-C; Linde C; Lund LH
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2016;69(12):1167

2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.

Ponikowski P; Voors AA; Anker SD; Bueno H; Cleland JGF; Coats AJS; Falk V; González-Juanatey JR; Harjola V-P; Jankowska EA; Jessup M; Linde C; Nihoyannopoulos P; Parissis JT; Pieske B; Riley JP; Rosano GMC; Ruilope LM; Ruschitzka F; Rutten FH; van der Meer P
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2016;18(10):1287-1297

Rationale and design of the PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm heart failure study: an epidemiological regional study in Stockholm county of 2.1 million inhabitants

Linde C; Eriksson MJ; Hage C; Wallen H; Persson B; Corbascio M; Lundeberg J; Maret E; Ugander M; Persson H
Article: BLOOD PRESSURE. 2016;25(5):286-291

Improvement of blood pressure control and physicians' management over time in patients with coronary artery disease

Hagglund O; Sjoqvist I; Linde C; Svensson P; Ostergren J
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2016;18(8):891-975

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC

Ponikowski P; Voors AA; Anker SD; Bueno H; Cleland JGF; Coats AJS; Falk V; Gonzalez-Juanatey JR; Harjola V-P; Jankowska EA; Jessup M; Linde C; Nihoyannopoulos P; Parissis JT; Pieske B; Riley JP; Rosano GMC; Ruilope LM; Ruschitzka F; Rutten FH; van der Meer P; Filippatos G; McMurray JJV; Aboyans V; Achenbach S; Agewall S; Al-Attar N; Atherton JJ; Bauersachs J; Camm AJ; Carerj S; Ceconi C; Coca A; Elliott P; Erol C; Ezekowitz J; Fernandez-Golfin C; Fitzsimons D; Guazzi M
Article: JACC-HEART FAILURE. 2016;4(2):129-136

Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure The DEFEAT-HF Study

Zipes DP; Neuzil P; Theres H; Caraway D; Mann DL; Mannheimer C; Van Buren P; Linde C; Linderoth B; Kueffer F; Sarazin SA; de Jongste MJL
Article: KARDIOLOGIA POLSKA. 2016;74(10):1037-1147

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Ponikowski P; Voors AA; Anker SD; Bueno H; Cleland JGF; Coats AJS; Falk V; Gonzalez-Juanatey JR; Harjola V-P; Jankowska EA; Jessup M; Linde C; Nihoyannopoulos P; Parissis JT; Pieske B; Riley JP; Rosano GMC; Ruilope LM; Ruschitzka F; Rutten FH; van der Meer P
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING. 2016;17(1):106-113

Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen study

Donal E; Lund LH; Oger E; Reynaud A; Schnell F; Persson H; Drouet E; Linde C; Daubert C
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2016;202:349-355

Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study

Linde C; Curtis AB; Fonarow GC; Lee K; Little W; Tang A; Levya F; Momomura S-I; Manrodt C; Bergemann T; Cowie MR
Article: EUROPEAN HEART JOURNAL. 2015;36(41):2780-2789

Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review

Chatterjee NA; Roka A; Lubitz SA; Gold MR; Daubert C; Linde C; Steffel J; Singh JP; Mela T
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2015;4(9):e002054

Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE)

Sutton MSJ; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
Article: EUROPACE. 2015;17(8):1169-1196

Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society

Boriani G; Savelieva I; Dan G-A; Deharo JC; Ferro C; Israel CW; Lane DA; La Manna G; Morton J; Mitjans AM; Vos MA; Turakhia MP; Lip GYH
Article: EUROPEAN HEART JOURNAL. 2015;36(26):1676-1688

The effect of duration of follow-up and presence of competing risk on lifespan-gain from implantable cardioverter defibrillator therapy: who benefits the most?

Raphael CE; Finegold JA; Barron AJ; Whinnett ZI; Mayet J; Linde C; Cleland JGF; Levy WC; Francis DP
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2015;17(7):680-688

New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study

Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat P-V; Bauer F; Drouet E; Linde C; Daubert C
Article: JACC-HEART FAILURE. 2015;3(4):327-336

Opportunity to Increase Life Span in Narrow QRS Cardiac Resynchronization Therapy Recipients by Deactivating Ventricular Pacing Evidence From Randomized Controlled Trials

Sohaib SMA; Finegold JA; Nijjer SS; Hossain R; Linde C; Levy WC; Sutton R; Kanagaratnam P; Francis DP; Whinnett ZI
Article: EUROPACE. 2015;17(3):439-446

Increase in paced heart rate reduces muscle sympathetic nerve activity in heart failure patients treated with cardiac resynchronization therapy

Stahlberg M; Sander M; Mortensen L; Linde C; Braunschweig F
Article: EUROPACE. 2015;17(3):424-431

Gender, underutilization of cardiac resynchronization therapy, and prognostic impact of QRS prolongation and left bundle branch block in heart failure

Linde C; Stahlberg M; Benson L; Braunschweig F; Edner M; Dahlstrom U; Alehagen U; Lund LH
Article: HEART RHYTHM. 2015;12(3):524-530

The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: Results of the REVERSE study

Gold MR; Daubert C; Abraham WT; Ghio S; Sutton MSJ; Hudnall JH; Cerkvenik J; Linde C
Article: OPEN HEART. 2015;2(1):e000260

Copeptin in patients with heart failure and preserved ejection fraction: a report from the prospective KaRen-study.

Hage C; Lund LH; Donal E; Daubert J-C; Linde C; Mellbin L
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2015;189:6-11

Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes

Zabarovskaja S; Hage C; Linde C; Daubert J-C; Donal E; Gabrielsen A; Mellbin L; Lunda LH
Article: EUROPACE. 2015;17(1):69-77

Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry

Gadler F; Valzania C; Linde C
Article: EUROPACE. 2015;17(1):137-141

European Cardiac Resynchronization Therapy Survey II: rationale and design

Dickstein K; Normand C; Anker SD; Auricchio A; Blomstrom CL; Bogale N; Cleland J; Filippatos G; Gasparini M; Gitt A; Hindricks G; Kuck K-H; Ponikowski P; Stellbrink C; Ruschitzka F; Linde C
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2014;16(10):1073-1081

Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14713 patients in the Swedish Heart Failure Registry

Lund LH; Benson L; Stahlberg M; Braunschweig F; Edner M; Dahlstrom U; Linde C
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2014;16(9):992-1001

Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction

Lund LH; Donal E; Oger E; Hage C; Persson H; Haugen-Lofman I; Ennezat P-V; Sportouch-Dukhan C; Drouet E; Daubert J-C; Linde C
Article: ARCHIVES OF CARDIOVASCULAR DISEASES. 2014;107(2):112-121

Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study

Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat P-V; Bauer F; Sportouch-Dukhan C; Drouet E; Daubert J-C; Linde C
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2014;67(1):58

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.

TheTask Force on cardiac pacing and resynchronizat; Brignole M; Auricchio A; Baron-Esquivias G; Bordachar P; Boriani G; Breithardt O-A; Cleland J; Deharo J-C; Delgado V; Elliott PM; Gorenek B; Israel CW; Leclercq C; Linde C; Mont L; Padeletti L; Sutton R; Vardas PE
Article: EUROPACE. 2014;16(1):109-128

New devices in heart failure: an European Heart Rhythm Association report

Kuck K-H; Bordachar P; Borggrefe M; Boriani G; Burri H; Leyva F; Schauerte P; Theuns D; Leyva F; Schauerte P; Theuns D; Thibault B
Article: EUROPEAN HEART JOURNAL. 2013;34(46):3547-3556

An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure

Cleland JG; Abraham WT; Linde C; Gold MR; Young JB; Daubert JC; Sherfesee L; Wells GA; Tang ASL
Article: CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY. 2013;6(6):1163-1168

Implantable Defibrillators Improve Survival in Patients With Mildly Symptomatic Heart Failure Receiving Cardiac Resynchronization Therapy Analysis of the Long-Term Follow-Up of Remodeling in Systolic Left Ventricular Dysfunction (REVERSE)

Gold MR; Daubert J-C; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2013;15(12):1419-1428

Meta-analysis of symptomatic response attributable to the pacing component of cardiac resynchronization therapy

Sohaib SMA; Chen Z; Whinnett ZI; Bouri S; Dickstein K; Linde C; Hayes DL; Manisty CH; Francis DP
Article: CIRCULATION-HEART FAILURE. 2013;6(6):1180-1189

Impact of Ejection Fraction on the Clinical Response to Cardiac Resynchronization Therapy in Mild Heart Failure

Linde C; Daubert C; Abraham WT; Sutton MSJ; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR
Article: EUROPEAN HEART JOURNAL. 2013;34(33):2592-2599

Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study

Linde C; Gold MR; Abraham WT; Sutton MSJ; Ghio S; Cerkvenik J; Daubert C
Article: EUROPACE. 2013;15(8):1182-1190

Haemodynamic effects of different basic heart rates in ambulatory heart failure patients treated with cardiac resynchronization therapy

Stahlberg M; Hilpisch K; Reiters P; Linde C; Braunschweig F
Article: INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 2013;29(2):140-146

COST-EFFECTIVENESS ANALYSIS OF CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH NYHA I AND NYHA II HEART FAILURE IN SPAIN

Almenar L; Diaz B; Quesada A; Crespo C; Marti B; Mealing S; Linde C; Daubert C
Article: EUROPEAN HEART JOURNAL. 2013;34(7):529-539

Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction

Lund LH; Jurga J; Edner M; Benson L; Dahlstrom U; Linde C; Alehagen U
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2012;14(12):1420-1428

Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study

Mathew J; Katz R; Sutton MSJ; Dixit S; Gerstenfeld EP; Ghio S; Gold MR; Linde C; Shlipak MG; Deo R
Article: HEART FAILURE REVIEWS. 2012;17(6):767-775

A plea for the wider use of CRT-P in candidates for cardiac resynchronisation therapy

Daubert J-C; Donal E; Linde C
Article: EUROPEAN HEART JOURNAL. 2012;33(21):2662-2671

Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial

Thebault C; Donal E; Meunier C; Gervais R; Gerritse B; Gold MR; Abraham WT; Linde C; Daubert J-C
Article: JACC-CARDIOVASCULAR IMAGING. 2012;5(10):1046-1065

The Limit of Plausibility for Predictors of Response: Application to Biventricular Pacing

Nijjer SS; Pabari PA; Stegemann B; Palmieri V; Leyva F; Linde C; Freemantle N; Davies JE; Hughes AD; Francis DP
Article: CIRCULATION. 2012;126(7):822-829

Effect of QRS Duration and Morphology on Cardiac Resynchronization Therapy Outcomes in Mild Heart Failure Results From the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) Study

Gold MR; Thebault C; Linde C; Abraham WT; Gerritse B; Ghio S; Sutton MSJ; Daubert J-C
Article: EUROPACE. 2012;14(8):1148-1155

Women have better long-term prognosis than men after cardiac resynchronization therapy

Zabarovskaja S; Gadler F; Braunschweig F; Stahlberg M; Hornsten J; Linde C; Lund LH
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING. 2012;13(8):656-665

Heart failure with a preserved ejection fraction additive value of an exercise stress echocardiography

Donal E; Thebault C; Lund LH; Kervio G; Reynaud A; Simon T; Drouet E; Nonotte E; Linde C; Daubert J-C
Article: HEART RHYTHM. 2012;9(8):S3-S13

Cardiac resynchronization therapy (CRT): Clinical trials, guidelines, and target populations

Linde C; Ellenbogen K; McAlister FA
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2012;14(1):61-73

The European CRT Survey: 1 year (9-15 months) follow-up results

Bogale N; Priori S; Cleland JGF; Brugada J; Linde C; Auricchio A; van Veldhuisen DJ; Limbourg T; Gitt A; Gras D; Stellbrink C; Gasparini M; Metra M; Derumeaux G; Gadler F; Buga L; Dickstein K
Article: EUROPACE. 2011;13(10):1445-1453

The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume

Bogale N; Priori S; Gitt A; Alings M; Linde C; Dickstein K
Article: ANNALS OF NONINVASIVE ELECTROCARDIOLOGY. 2011;16(4):327-335

Paroxysmal Regular Supraventricular Tachycardia: The Diagnostic Accuracy of the Transesophageal Ventriculo-Atrial Interval

Braunschweig F; Christel P; Jensen-Urstad M; Andersson M; Schwieler J; Tapanainen J; Bastani H; Gadler F; Linde C; Schoels W; Bergfeldt L
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2011;13(9):974-983

The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades

Bogale N; Witte K; Priori S; Cleland J; Auricchio A; Gadler F; Gitt A; Limbourg T; Linde C; Dickstein K
Article: EUROPACE. 2011;13(9):1327-1334

Transient repolarization instability following the initiation of cardiac resynchronization therapy

Braunschweig F; Pfizenmayer H; Rubulis A; Schoels W; Linde C; Bergfeldt L
Article: EUROPEAN HEART JOURNAL. 2011;32(13):1631-1639

Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction)

Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert J-C
Article: BIOMEDICAL ENGINEERING ONLINE. 2011;10:36

Estimation of cardiac output in patients with congestive heart failure by analysis of right ventricular pressure waveforms

Karamanoglu M; Bennett T; Stahlberg M; Splett V; Kjellstroem B; Linde C; Braunschweig F
Article: HEART RHYTHM. 2011;8(5):679-684

The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure

Gold MR; Linde C; Abraham WT; Gardiwal A; Daubert J-C
Article: EUROPACE. 2011;13(2):237-243

Acute haemodynamic effects of increase in paced heart rate in heart failure patients recorded with an implantable haemodynamic monitor

Stahlberg M; Kessels R; Linde C; Braunschweig F
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2010;56(22):1826-1831

Cardiac Resynchronization Therapy in Asymptomatic or Mildly Symptomatic Heart Failure Patients in Relation to Etiology Results From the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) Study

Linde C; Abraham WT; Gold MR; Daubert C
Article: CIRCULATION. 2010;122(10):1037-1043

Cardiac Resynchronization Therapy in Patients With New York Heart Association Class I and II Heart Failure An Approach to 2010

Linde C; Daubert C
Article: LAKARTIDNINGEN. 2010;107(6):368-370

[What determines successful heart transplantation care? Low volume alone does not explain the decrease in 1-year survival].

Hultman J; Tibell A; Linde C
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2009;104(10):1434-1440

Predisposing Factors and Consequences of Elevated Biomarker Levels in Long-Distance Runners Aged ≥55 Years

Sahlen A; Gustafsson TP; Svensson JE; Marklund T; Winter R; Linde C; Braunschweig F
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2009;54(20):1837-1846

Prevention of Disease Progression by Cardiac Resynchronization Therapy in Patients With Asymptomatic or Mildly Symptomatic Left Ventricular Dysfunction Insights From the European Cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) Trial

Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Torok T; Linde C
Article: CIRCULATION. 2009;120(19):1858-1865

Cardiac Resynchronization Induces Major Structural and Functional Reverse Remodeling in Patients With New York Heart Association Class I/II Heart Failure

Sutton MSJ; Ghio S; Plappert T; Tavazzi L; Scelsi L; Daubert C; Abraham WT; Gold MR; Hassager C; Herre JM; Linde C
Article: EUROPACE. 2009;11:v72-v76

Cardiac resynchronization therapy in mild heart failure

Linde C
Article: EUROPEAN HEART JOURNAL. 2009;30(20):2450-2460

The European cardiac resynchronization therapy survey

Dickstein K; Bogale N; Priori S; Auricchio A; Cleland JG; Gitt A; Limbourg T; Linde C; van Veldhuisen DJ; Brugada J
Article: EUROPACE. 2009;11(9):1160-1167

Cardiac output response to changes of the atrioventricular delay in different body positions and during exercise in patients receiving cardiac resynchronization therapy

Stahlberg M; Damgaard M; Norsk P; Gabrielsen A; Sahlen A; Linde C; Braunschweig F
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2009;11(6):594-601

Continuous central haemodynamic measurements during the six-minute walk test and daily life in patients with chronic heart failure

Braunschweig F; Linde C; Adamson PB; Magalski A; Erdmann E; Kjellstrom B; Bennett T
Article: EUROPACE. 2009;11(6):716-726

Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population

Cowie MR; Marshall D; Drummond M; Ferko N; Maschio M; Ekman M; de Roy L; Heidbuchel H; Verboven Y; Braunschweig F; Linde C; Boriani G
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2009;11(3):326-330

European cardiac resynchronization therapy survey: rationale and design

Dickstein K; Priori S; Auricchio A; Terradellas JB; Cleland J; Derumeaux G; Gras D; Komajda M; Linde C; Morgan J; van Veldhuisen DJ; Gitt A; Bogale N
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2009;11(2):198-204

Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction

Donal E; Lund LH; Linde C; Edner M; Lafitte S; Persson H; Bauer F; Ohrvik J; Ennezat P-V; Hage C; Loefman I; Juilliere Y; Logeart D; Derumeaux G; Gueret P; Daubert J-C
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2009;103(1):119-123

Changes in Right Ventricular Pressures Between Hemodialysis Sessions Recorded by an Implantable Hemodynamic Monitor

Kjellstroem B; Braunschweig F; Lofberg E; Fux T; Grandjean P-A; Linde C
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2008;52(23):1834-1843

Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms

Linde C; Abraham WT; Gold MR; Sutton MSJ; Ghio S; Daubert C
Article: EUROPACE. 2008;10(7):825-831

Atrial vs. dual-chamber cardiac pacing in sinus node disease: a register-based cohort study

Fored CM; Granath F; Gadler F; Blomqvist P; Rynder J; Linde C; Ekbom A; Rosenqvist M
Article: CONGESTIVE HEART FAILURE. 2008;14(2):66-74

Baseline characteristics of patients randomized in The Resynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunction (REVERSE) study.

Linde C; Gold M; Abraham WT; Daubert J-C; REVERSE Study Group
Article: CIRCULATION. 2008;117(18):F103-F105

Centres of excellence: Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden

Linde C; Pernow J
Article: EUROPEAN HEART JOURNAL SUPPLEMENTS. 2007;9(I):I3-I10

History of electrical therapy for the heart

Sutton R; Fisher JD; Linde C; Benditt DG
Article: EUROPEAN HEART JOURNAL SUPPLEMENTS. 2007;9(I):I94-I106

Cardiac resynchronization therapy: clinical results and evolution of candidate selection

Leclercq C; Bleeker GB; Linde C; Donal E; Bax JJ; Schalij MJ; Daubert C
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2006;8(8):797-803

Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure

Braunschweig F; Fahrleitner-Pammer A; Mangiavacchi M; Ghio S; Fotuhi P; Hoppe UC; Linde C
Article: AMERICAN HEART JOURNAL. 2006;151(2):288-294

Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure - the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study

Linde C; Gold M; Abraham WT; Daubert JC
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2006;21(1):176-183

Dynamic changes in right ventricular pressures during haemodialysis recorded with an implantable haemodynamic monitor

Braunschweig F; Kjellström B; Söderhäll M; Clyne N; Linde C
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2005;46(12):2168-2182

Cardiac resynchronization therapy - Part 2 - Issues during and after device

Bax JJ; Abraham T; Barold SS; Breithardt OA; Fung JWH; Garrigue S; Gorcsan J; Hayes DL; Kass DA; Knuuti J; Leclercq C; Linde C; Mark DB; Monaghan MJ; Nihoyannopoulos P; Schalij MJ; Stellbrink C; Yu CM
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2005;46(12):2153-2167

Cardiac resynchronization therapy - Part 1 - Issues before device implantation

Bax JJ; Abraham T; Barold SS; Breithardt OA; Fung JWH; Garrigue S; Gorcsan J; Hayes DL; Kass DA; Knuuti J; Leclercq C; Linde C; Mark DB; Monaghan MJ; Nihoyannopoulos P; Schalij MJ; Stellbrink C; Yu CM
Article: EUROPACE. 2005;7(6):611-616

Left atrial far-field sensing leads: A potential hazard in resynchronisation therapy

Taieb JM; Barnay C; Linde C; Mortensen P; Menardis M
Article: PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. 2005;28(10):1013-1017

Three year outcome of cardiac resynchronization therapy:: A single center evaluation

Ståhlberg M; Braunschweig F; Gadler F; Karlsson H; Linde C
Article: PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. 2005;28(6):561-567

Pacing-induced electrophysiological remodeling in hypertrophic obstructive cardiomyopathy - Observations on cardiac memory

Nowinski K; Wecke L; Gadler F; Linde C; Bergfeldt L
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2005;95(9):1104-1107

Monitoring of physical activity and heart rate variability in patients with chronic heart failure using cardiac resynchronization devices

Braunschweig F; Mortensen PT; Gras D; Reiser W; Lawo T; Mansour H; Sogaard P; Stegemann B; Bruns HJ; Linde C
Article: HEART RHYTHM. 2005;2(1):28-34

Temporal characteristics of cardiac memory in humans: Vectorcardiographic quantification in a model of cardiac pacing

Wecke L; Gadler F; Linde C; Lundahl G; Rosen MR; Bergfeldt L
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2004;6(5):627-634

Six years follow-up of an implanted SvO₂ sensor in the right ventricle

Kjellström B; Linde C; Bennetta T; Ohlsson A; Ryden L
Article: HEART. 2004;90(2):231-234

Implantable cardioverter-defibrillator treatment and resynchronisation in heart failure

Linde C
Article: JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY. 2004;15(1):94-96

Optimization of cardiac resynchronization therapy by continuous hemodynamic monitoring:: A case report

Braunschweig F; Kjellström B; Gadler F; Linde C
Article: PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. 2003;26(7):1461-1466

Rapid atrial pacing does not decrease the atrial defibrillation threshold

Frykman V; Darpö B; Ayers GM; Bergfeldt L; Linde C; Rosenqvist M
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2003;92(1):95-99

Effects of biventricular pacing on myocardial blood flow and oxygen consumption using carbon-11 acetate positron emission tomography in patients with heart failure

Braunschweig F; Sörensen J; von Bibra H; Olsson A; Rydén L; Långström B; Linde C
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2003;91(9):1090-1095

Long-term improvements in quality of life by biventricular pacing in patients with chronic heart failure: Results from the MUltisite STimulation in Cardiomyopathy Study (MUSTIC)

Linde C; Braunschweig F; Gadler F; Bailleul C; Daubert JC
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2003;41(4):565-571

Ongoing right ventricular hemodynarnics in heart failure -: Clinical value of measurements derived from an implantable monitoring system

Adamson PB; Magalski A; Braunschweig F; Böhm M; Reynolds D; Steinhaus D; Luby A; Linde C; Ryden L; Cremers B; Takle T; Bennett T
Article: EUROPEAN HEART JOURNAL. 2002;23(22):1780-1787

Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation

Leclercq C; Walker S; Linde C; Clementy J; Marshall AJ; Ritter P; Djiane P; Mabo P; Levy T; Gadler F; Bailleul C; Daubert JC
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2002;40(1):111-118

Long-term benefits of biventricular pacing in congestive heart failure: Results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study

Linde C; Leclercq C; Rex S; Garrigue S; Lavergne T; Cazeau S; McKenna W; Fitzgerald M; Deharo JC; Alonso C; Walker S; Braunschweig F; Bailleul C; Daubert JC
Article: JOURNAL OF CARDIAC FAILURE. 2002;8(2):63-70

Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor:: A multicenter, 12-month follow-up study of patients with chronic heart failure

Magalski A; Adamson P; Gadler F; Böehm M; Steinhaus D; Reynolds D; Vlach K; Linde C; Cremers B; Sparks B; Bennett T
Article: EUROPEAN HEART JOURNAL. 2002;23(1):59-69

Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure

Braunschweig F; Linde C; Eriksson MJ; Hofman-Bang C; Rydén L
Article: PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. 2001;24(11):1664-1671

Combipolar sensing in dual chamber pacing:: Is there still a need for bipolar leads in the atrium?

Linde C; Markewitz A; Strandberg H; Larsson B; Binner L; Schüller H
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2001;344(12):873-880

Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.

Cazeau S; Leclercq C; Lavergne T; Walker S; Varma C; Linde C; Garrigue S; Kappenberger L; Haywood GA; Santini M; Bailleul C; Daubert JC
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2000;2(4):399-406

Reduction of hospital days by biventricular pacing

Braunschweig F; Linde C; Gadler F; Rydén L
Article: LAKARTIDNINGEN. 2000;97(40):4450-4458

[Biventricular pacing as a new therapeutic method in heart failure. An alternative for patients with intraventricular conduction disorders].

Braunschweig F; Gadler F; Linde C; Kjellström B; Rydén L
Article: EUROPEAN HEART JOURNAL. 1999;20(14):1044-1050

Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy - Data from 1 year of follow-up

Gadler F; Linde C; Daubert C; McKenna W; Meisel E; Aliot E; Chojnowska L; Guize L; Gras D; Jeanrenaud X; Kappenberger L
Article: AMERICAN JOURNAL OF CARDIOLOGY. 1999;83(6):903-907

Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy

Linde C; Gadler F; Kappenberger L; Rydén L
Article: AMERICAN JOURNAL OF CARDIOLOGY. 1999;83(4):553-557

Rapid return of left ventricular outflow tract obstruction and symptoms following cessation of long-term atrioventricular synchronous pacing for obstructive hypertrophic cardiomyopathy

Gadler F; Linde C; Rydén L
Article: EUROPEAN HEART JOURNAL. 1998;19(1):132-138

Modification of atrioventricular conduction as adjunct therapy for pacemaker-treated patients with hypertrophic obstructive cardiomyopathy

Gadler F; Linde C; Darpo B
Article: AMERICAN JOURNAL OF CARDIOLOGY. 1997;80(9):1174-1177

Incidence of sudden death after radiofrequency ablation of the atrioventricular junction for atrial fibrillation

Darpo B; Walfridsson H; Aunes M; Bergfeldt L; Edvardsson N; Linde C; Lurje L; vanderLinden M; Rosenqvist M
Article: EUROPEAN HEART JOURNAL. 1997;18(4):636-642

Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest

Gadler F; Linde C; JuhlinDannfelt A; Ribeiro A; Ryden L
Article: LAKARTIDNINGEN. 1996;93(41):3566-3572

[Pacemaker in hypertrophic obstructive cardiomyopathy. A new efficient treatment of heart disease].

Gadler F; Juhlin-Dannfelt A; Linde C; Ribeiro A; Rydén L
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1996;27(5):1219-1224

Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy

Gadler F; Linde C; JuhlinDannfelt A; Ribeiro A; Ryden L
Article: AMERICAN JOURNAL OF CARDIOLOGY. 1995;75(14):919-923

RESULTS OF ATRIOVENTRICULAR SYNCHRONOUS PACING WITH OPTIMIZED DELAY IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE

LINDE C; GADLER F; EDNER M; NORDLANDER R; ROSENQVIST M; RYDEN L
Visa fler

Alla övriga publikationer

Editorial comment: JACC-CLINICAL ELECTROPHYSIOLOGY. 2024;10(7):1465-1467

CRT for Dilated Cardiomyopathy Time for a Personalized Approach

Linde C
Editorial comment: EUROPEAN HEART JOURNAL. 2023;44(40):4270-4271

The BUDAPEST trial: a good grade for upgrades in heart failure with reduced ejection fraction

Linde C
Editorial comment: LANCET. 2023;402(10408):1110-1112

Will the results from the AdaptResponse trial boost CRT use?

Linde C
Review: EUROPACE. 2023;25(8):euad168

The evolving state of cardiac resynchronization therapy and conduction system pacing: 25 years of research at EP Europace journal

Ellenbogen KA; Auricchio A; Burri H; Gold MR; Leclercq C; Leyva F; Linde C; Jastrzebski M; Prinzen F; Vernooy K
Preprint: MEDRXIV. 2023;MEDRXIV

Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis.

Shivakumar N; Friedman DJ; Fudim M; Abraham WT; Cleland JGF; Curtis AB; Gold MR; Kutyifa V; Linde C; Young J; Tang A; Olivas-Martinez A; Inoue LYT; Sanders GD; Al-Khatib SM
Review: KARDIOLOGIA POLSKA. 2023;81(1):7-13

Cardiac resynchronization in heart failure: Recent advances and their practical implications

Linde C
Review: EUROPEAN HEART JOURNAL. 2022;43(27):2562-2569

A systematic review and meta-analysis of beta-blockers and renin-angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer

Lewinter C; Nielsen TH; Edfors LR; Linde C; Bland JM; LeWinter M; Cleland JGF; Kober L; Braunschweig F; Mansson-Broberg A
Editorial comment: EUROPEAN HEART JOURNAL. 2022;43(27):2600-2602

CRT-P or CRT-D in heart failure patients: the RESET-CRT project-a prelude to the randomized controlled RESET-CRT study

Linde C
Editorial comment: EUROPEAN HEART JOURNAL. 2022;43(23):2181-2184

The European Heart Journal: fulfilling the mission

Crea F; Badimon L; Berry C; De Caterina R; Elliott PM; Hatala R; Libby P; Linde C; Tybjaerg-Hansen A
Review: EUROPEAN HEART JOURNAL. 2022;43(20):1917-1927

Electrical management of heart failure: from pathophysiology to treatment

Prinzen FW; Auricchio A; Mullens W; Linde C; Huizar JF
Editorial comment: EUROPEAN HEART JOURNAL. 2021;42(46):4740-4742

Pace and ablate better than drugs in patients with heart failure and atrial fibrillation: lessons from the APAF-CRT mortality trial

Linde C
Review: EUROPEAN HEART JOURNAL. 2021;42(35):3427-3520

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)

Glikson M; Nielsen JC; Kronborg MB; Michowitz Y; Auricchio A; Barbash IM; Barrabes JA; Boriani G; Braunschweig F; Brignole M; Burri H; Coats AJS; Deharo J-C; Delgado V; Diller G-P; Israel CW; Keren A; Knops RE; Kotecha D; Leclercq C; Merkely B; Starck C; Thylen I; Maria Tolosana J
Other: EUROPACE. 2021;25(6):euab035

Optimized Implementation of cardiac resynchronization therapy - a call for action for referral and optimization of care (Withdrawal of Vol 23, art no 1324, 2021)

Mullens W; Auricchio A; Martens P; Witte K; Cowie MR; Delgado V; Dickstein K; Linde C; Vernooy K; Leyva F; Bauersachs J; Israel CW; Lund L; Donal E; Boriani G; Jaarsma T; Berruezo A; Traykov V; Yousef Z; Kalarus Z; Cosedis Nielsen J; Steffel J; Vardas P; Coats A; Seferovic P; Edvardsen T; Heidbuchel H; Ruschitzka F; Leclercq C
Editorial comment: EUROPEAN HEART JOURNAL. 2021;42(5):517-519

Pacing for repeated vagal reflex-mediated syncope: an old problem with a solution

Linde C; Crijns HJGM
Editorial comment: EUROPEAN HEART JOURNAL. 2021;42(5):365-367

A new era for the young community of the ESC

Sohaib A; Linde C
Editorial comment: EUROPEAN JOURNAL OF HEART FAILURE. 2020;22(12):2349-2369

Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology

Mullens W; Auricchio A; Martens P; Witte K; Cowie MR; Delgado V; Dickstein K; Linde C; Vernooy K; Leyva F; Bauersachs J; Israel CW; Lund LH; Donal E; Boriani G; Jaarsma T; Berruezo A; Traykov V; Yousef Z; Kalarus Z; Cosedis Nielsen J; Steffel J; Vardas P; Coats A; Seferovic P; Edvardsen T; Heidbuchel H; Ruschitzka F; Leclercq C
Review: ACTA CARDIOLOGICA. 2020;75(6):492-496

Benchmarking Belgian CRT practice against the rest of Europe: insights from the ESC-CRT survey II

Gauthey A; Willems R; Vandekerckhove Y; Mullens W; Stefan L; Carryn X; Blommaert D; Mairesse G; Dickstein K; Normand C; Linde C; Le Polain de Waroux J-B
Editorial comment: EUROPEAN HEART JOURNAL. 2020;41(33):3113-3116

The European Heart Journal: leading the fight to reduce the global burden of cardiovascular disease

Crea F; Badimon L; Berry C; De Caterina R; Elliott PM; Hatala R; Libby P; Linde C; Tybjaerg-Hansen A
Editorial comment: EUROPEAN HEART JOURNAL. 2020;41(30):2845-2847

Integrated care for atrial fibrillation: time for widespread use

Linde C
Corrigendum: IRISH JOURNAL OF MEDICAL SCIENCE. 2020;189(3):941

CRT Survey II: a European Society of Cardiology (ESC) survey of cardiac resynchronization therapy-an Irish subset analysis (vol 56, pg 971, 2020)

Ranganathan D; Sharif Z; Murphy T; Mahon N; Sheahan CR; Normand C; Linde C; Dickstein K; Sheahan R
Editorial comment: JOURNAL OF CARDIAC FAILURE. 2020;26(5):440-443

Increased iron absorption in patients with chronic heart failure and iron deficiency

Cabrera CC; Ekstrom M; Linde C; Persson H; Hage C; Eriksson MJ; Wallen H; Persson B; Tornvall P; Lynga P
Letter: CIRCULATION. 2020;141(11):e648-e649

Response by Schrage et al to Letter Regarding Article, "Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure Registry"

Schrage B; Linde C; Braunschweig F; Savarese G
Editorial comment: CARDIOVASCULAR RESEARCH. 2019;115(12):e130-e132

The Membership Committee of the ESC

Linde C; Glikson M; Mascherbauer J; Motovska Z; Gielen S; Bouleti C; Celutkiene J; Porter A; Pearson J; Caforio A; Cosyns B; Haugaa K; Deharo J-C; Grecu M; Dendale P; Castelletti S; Gevaert S; Ayala AS; Haude M; Gilard M; Lainscak M; Jankowska EA; Marques-Sule E; Neubeck L; Tok OO; Gara E; Konstantinides S; Konstantinides S; Wolpert C; Raatikainen P; Pavlovic N
Review: EUROPEAN HEART JOURNAL. 2019;40(21):1720-1727

The future of continuing medical education: the roles of medical professional societies and the health care industry Position paper prepared with contributions from the European Society of Cardiology Committees for Advocacy, Education and Industry Relations, Endorsed by the Board of the European Society of Cardiology

Bax J; Casadei B; Graham I; Pinto F; Anker S; Badimon L; Merkaly B; Bueno H; Clarke S; Fitzsimons D; Leclerq C; Linde C; Weidinger F; Lettino M; Popescu B; Grobbee D; Haude M; Hindricks G; Ruschitzka F; Achenbach S; Clarke N; Cosentino F; Filippatos G; Kearney P; Kirchhof P; Kristensen SD; Luscher T; Olsson G; Vahanian A; Windecker S; Zamorano J
Corrigendum: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2018;261:240

Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study (vol 226, pg 65, 2017)

Savarese G; Donal E; Hage C; Oger E; Persson H; Daubert J-C; Linde C; Lund LH
Review: EUROPACE. 2018;20(6):908-920

Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions

Daubert C; Gadler F; Mabo P; Linde C
Editorial comment: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2018;71(3):318-320

Cardiomyopathy and Left Bundle Branch Block A Farewell to Drugs?

Linde C; Braunschweig F
Review: MEDICAL SCIENCE MONITOR BASIC RESEARCH. 2017;23:179-222

Prediction of New-Onset and Recurrent Atrial Fibrillation by Complete Blood Count Tests: A Comprehensive Systematic Review with Meta-Analysis.

Weymann A; Ali-Hasan-Al-Saegh S; Sabashnikov A; Popov A-F; Mirhosseini SJ; Liu T; Lotfaliani M; Sá MPBDO; Baker WLL; Yavuz S; Zeriouh M; Jang J-S; Dehghan H; Meng L; Testa L; D'Ascenzo F; Benedetto U; Tse G; Nombela-Franco L; Dohmen PM; Deshmukh AJ; Linde C; Biondi-Zoccai G; Stone GW; Calkins H; Surgery And Cardiology-Group Imcsc-Group IM-AOC
Review: HEART RHYTHM. 2017;14(5):763-782

The burden of proof: The current state of atrial fibrillation prevention and treatment trials

Zakeri R; Van Wagoner DR; Calkins H; Wong T; Ross HM; Heist EK; Meyer TE; Kowey PR; Mentz RJ; Cleland JG; Pitt B; Zannad F; Linde C
Letter: EUROPEAN JOURNAL OF HEART FAILURE. 2017;19(2):283-286

Spinal cord stimulation in heart failure: effect on disease-associated biomarkers

Naar J; Jaye D; Linde C; Neuzil P; Doskar P; Malek F; Braunschweig F; Lund LH; Mortensen L; Back M; Linderoth B; Lind G; Kueffer F; Koehler J; Shahgaldi K; Stahlberg M
Review: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2016;50(5-6):282-292

Cardiac resynchronization therapy: results, challenges and perspectives for the future

Stahlberg M; Braunschweig F; Gadler F; Mortensen L; Lund LH; Linde C
Review: EUROPEAN HEART JOURNAL. 2016;37(27):2129-2200

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Ponikowski P; Voors AA; Anker SD; Bueno H; Cleland JGF; Coats AJS; Falk V; Ramon Gonzalez-Juanatey J; Harjola V-P; Jankowska EA; Jessup M; Linde C; Nihoyannopoulos P; Parissis JT; Pieske B; Riley JP; Rosano GMC; Ruilope LM; Ruschitzka F; Rutten FH; van der Meer P
Review: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2016;214:320-330

Neural modulation for hypertension and heart failure

Smith S; Rossignol P; Willis S; Zannad F; Mentz R; Pocock S; Bisognano J; Nadim Y; Geller N; Ruble S; Linde C
Review: LAKARTIDNINGEN. 2016;113:DYIE

[Cardiotoxicity relatively common in cancer treatment].

Bühlmann Lerjen E; Hübbert L; Papakonstantinou A; Hedayati E; Linde C; Månsson Broberg A
Editorial comment: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2016;67(18):2158-2160

Biventricular Stimulation A BLOCKbuster in Cardiac Pacing?

Braunschweig F; Linde C
Review: EUROPACE. 2016;18(1):12-36

European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society

Lip GYH; Heinzel FR; Gaita F; Gonzalez Juanatey JR; Le Heuzey JY; Potpara T; Svendsen JH; Vos MA; Anker SD; Coats AJ; Haverkamp W; Manolis AS; Chung MK; Sanders P; Pieske B
Review: CARDIAC ELECTROPHYSIOLOGY CLINICS. 2015;7(4):797-807

Cardiac Resynchronization Therapy Follow-up: Role of Remote Monitoring.

Linde C; Braunschweig F
Editorial comment: EUROPEAN JOURNAL OF HEART FAILURE. 2015;17(9):881-883

Cardiac resynchronization revisited: what is the next step?

Linde C
Editorial comment: EUROPEAN HEART JOURNAL. 2015;36(30):1948-1951

Reflections on EchoCRT: sound guidance on QRS duration and morphology for CRT?

Cleland JGF; Mareev Y; Linde C
Editorial comment: EUROPACE. 2015;17(2):171-173

When cardiac resynchronization therapy may be harmful: time to wake up

Linde C
Review: EUROPEAN JOURNAL OF HEART FAILURE. 2015;17(2):135-143

Cardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunction

Hai OY; Mentz RJ; Zannad F; Gasparini M; De Ferrari GM; Daubert J-C; Holzmeister J; Lam CSP; Pochet T; Vincent A; Linde C
Editorial comment: EUROPEAN JOURNAL OF HEART FAILURE. 2014;16(11):1157-1159

How do patients with previous RV pacing respond to upgrading to CRT? Important messages for pacemaker and ICD follow-up

Linde C
Review: NATURE REVIEWS CARDIOLOGY. 2014;11(10):576-585

Trials of implantable monitoring devices in heart failure: which design is optimal?

Abraham WT; Stough WG; Pina IL; Linde C; Borer JS; De Ferrari GM; Mehran R; Stein KM; Vincent A; Yadav JS; Anker SD; Zannad F
Review: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2014;175(1):30-37

Current challenges for clinical trials of cardiovascular medical devices

Zannad F; Stough WG; Pina IL; Mehran R; Abraham WT; Anker SD; De Ferrari GM; Farb A; Geller NL; Kieval RS; Linde C; Redberg RF; Stein K; Vincent A; Woehrle H; Pocock SJ
Review: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2013;170(2):118-131

Cardiac resynchronisation therapy optimisation strategies: Systematic classification, detailed analysis, minimum standards and a roadmap for development and testing

Sohaib SMA; Whinnett ZI; Ellenbogen KA; Stellbrink C; Quinn TA; Bogaard MD; Bordachar P; van Gelder BM; van Geldorp IE; Linde C; Meine M; Prinzen FW; Turcott RG; Spotnitz HM; Wichterle D; Francis DP
Letter: JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2013;32(6):651-654

Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator: A pilot study

Zabarovskaja S; Gadler F; Gabrielsen A; Linde C; Lund LH
Review: JOURNAL OF INTERNAL MEDICINE. 2012;272(4):330-343

Cardiac resynchronization therapy: a breakthrough in heart failure management

Stahlberg M; Lund LH; Zabarovskaja S; Gadler F; Braunschweig F; Linde C
Published conference paper: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2010;44(4):201-208

Estimating changes in cardiac output using an implanted hemodynamic monitor in heart failure patients

Stahlberg M; Damgaard M; Ersgard D; Norsk P; Karamanoglu M; Linde C; Braunschweig F
Review: ARCHIVES OF CARDIOVASCULAR DISEASES. 2010;103(6-7):404-410

Is cardiac resynchronization therapy an option in heart failure patients with preserved ejection fraction? Justification for the ongoing KaRen project

Donal E; Lund L; Linde C; Daubert J-C
Editorial comment: EUROPEAN HEART JOURNAL. 2010;31(4):388-389

Women physicians in cardiology and academia

Linde C; Baumgartner I
Letter: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2009;53(23):2198-2199

No Benefit From Cardiac Resynchronization Therapy in Asymptomatic Patients Reply

Linde C; Abraham WT; Gold MR; Sutton MSJ; Ghio S; Daubert C
Conference publication: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2009;53(10):A183

The Influence of Left Ventricular Ejection Fraction on the Extent of Reverse Remodeling by Cardiac Resynchronization Therapy in Mild Heart Failure: Results From the REsynchronization reVErses Remodeling in Systolic left vEntricular Dysfunction (REVERSE) Study

Linde C; Daubert C; Abraham WT; Gold MR; Hassager C; Herre JM; Ghio S; Sutton MSJ; Derumeaux G
Review: EUROPEAN JOURNAL OF HEART FAILURE. 2008;10(12):1229-1235

Successful treatment of heart failure with devices requires collaboration

Swedberg K; Cleland J; Cowie MR; Nieminen M; Priori SG; Tavazzi L; van Veldhuisen DJ; Alonso-Pulpon L; Camm J; Dickstein K; Drexler H; Filippatos G; Linde C; Lopez-Sendon J; Santini M; Zannad F
Letter: EUROPACE. 2008;10(4):511-512

What is the level of evidence for combined cardiac resynchronization and defibrillation therapy in heart failure? reply

Vardas PE; Auricchio A; Blanc J-J; Daubert J-C; Drexler H; Ector H; Gasparini M; Linde C; Morgado FB; Oto A; Sutton R; Trusz-Gluza M
Review: CURRENT HEART FAILURE REPORTS. 2008;5(1):51-55

Future directions in cardiac resynchronization therapy.

Linde C
Letter: EUROPEAN HEART JOURNAL. 2008;29(5):683-684

What is the level of evidence for combined cardiac resynchronization and defibrillation therapy in heart failure? reply

Vardas PE; Auricchio A; Blanc J-J; Daubert J-C; Drexler H; Ector H; Gasparini M; Linde C; Morgado FB; Oto A; Sutton R; Trusz-Gluza M
Editorial comment: EUROPEAN HEART JOURNAL SUPPLEMENTS. 2007;9(I):I1-I2

Celebrating 50 years of electrical therapies for the heart

Boriani G; Linde C; Sutton R
Review: EUROPEAN HEART JOURNAL. 2006;27(9):1018-1025

Effects of cardiac resynchronization therapy on disease progression in chronic heart failure

Donal E; Leclercq C; Linde C; Daubert JC
Editorial comment: REVISTA ESPANOLA DE CARDIOLOGIA. 2005;58(9):1062-1092

Guidelines for the Diagnosis and Treatment of Chronic Heart Failure:: Executive summary (Update 2005)

Swedberg K; Cleland J; Dargie H; Drexler H; Follath F; Komajda M; Tavazzi L; Smiseth OA; Gavazzi A; Haverich A; Hoes A; Jaarsma T; Korewicki J; Lévy S; Linde C; López-Sendón JL; Nieminen MS; Piérard L; Remme WJ
Review: EUROPEAN HEART JOURNAL. 2005;26(11):1115-1140

Guidelines for the diagnosis and treatment of chronic heart failure:: executive summary (update 2005)

Swedberg K; Cleland J; Dargie H; Drexler H; Follath F; Komajda M; Tavazzi L; Smiseth OA; Gavazzi A; Haverich A; Hoes A; Jaarsma T; Korewicki J; Lévy S; Linde C; Lopez-Sendon JL; Nieminen MS; Piérard L; Remme WJ
Letter: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2003;41(4):709-710

Efficacy of biventricular pacing in congestive heart failure - Reply

Linde C
Published conference paper: JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY. 2002;13(1):S68-S72

Continuous hemodynamic monitoring in heart failure

Braunschweig F; Linde C
Review: PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. 2000;23(10):1550-1560

Women and arrhythmias

Linde C
Editorial comment: HEART. 2000;84(2):123-124

Biventricular pacing in patients with severe heart failure: has the time come?

Linde C
Editorial comment: PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. 2000;23(6):931-933

Quality-of-life in pacemaker and implantable cardioverter defibrillator recipients

Linde C
Review: LAKARTIDNINGEN. 1999;96(11):1294-1299

[It is not easy to examine the causes of fainting. Vasovagal syncope is mostly not dangerous, cardiac syncope is potentially life-threatening].

Linde C
Published conference paper: EUROPEAN HEART JOURNAL SUPPLEMENTS. 1999;1(G):G8-G11

Reuse of pacemakers

Linde C
Editorial comment: PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. 1996;19(4):391-397

How to evaluate quality-of-life in pacemaker patients: Problems and pitfalls

Linde C
Editorial comment: PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. 1995;18(7):1341-1345

PACING IN DILATED CARDIOMYOPATHY

LINDE C; RYDEN L
Visa fler

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI